Log In

Lineage Cell Therapeutics, Inc. (LCTX)

CFO Left, Reiterating Outperform Rating

January 21, 2021
Report ID: 11953
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ā€˜Get Reportā€™ button to login and view the research report.

Not a Member? Click ā€˜Joinā€™ or ā€˜Get Reportā€™ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

ā€Œ
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc.
Healthcare
Biotechnology
Ticker
LCTX
Current Price
$1.27 -1.55%
Market Cap
$222.2M
Price Target
Refer to Report
Volume
303.5K
52wk Range
$1.02 - $1.58
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
2/16/2023
ā€Œ
Dropping Coverage
Dropping Coverage (LCTX)
0 min read
8/15/2022
ā€Œ
OpRegen Collaboration Advances As Pipeline Products Move Toward INDs
OpRegen Collaboration Advances As Pipeline Products Move Toward INDs (LCTX)
0 min read
5/13/2022
ā€Œ
1Q22 Reported With Clinical Program Review
1Q22 Reported With Clinical Program Review (LCTX)
0 min read
4/26/2022
ā€Œ
New Program Added To The Development Pipeline
New Program Added To The Development Pipeline (LCTX)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
Ā© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In